No Underlying Cause: A Case of a Fatal Neuroendocrine Lung Tumor
Main Article Content
Abstract
A 34 year old female with metastasizing neuroendocrine lung carcinoma with no underlying etiologies. Patient was diagnosed with stage 4 lung neuroendocrine cancer with treatment options limited due to intellectual disability and overall poor prognosis. The patient had a rapid decline over a 5 week period with decreased intake, decreased appetite, and overall azotemia and resulted in patient’s death.
Downloads
Article Details
Copyright (c) 2019 Dennison A, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Dasari A, Shen C, Halperin D (2017) Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol 3: 1335-1342. Link: https://bit.ly/2ZAkeUd
Thomas C, Jett J, Strosberg J (2018) Lung neuroendocrine (carcinoid) tumors: Epidemiology, risk factors, classification, histology, diagnosis, and staging. UpToDate. Link: https://bit.ly/2x1zMUN
Rekhtman N (2010) Neuroendocrine tumors of the lung: an update. Arch Pathol Lab Med 134: 1628-1638. Link: https://bit.ly/2XXNWlL
Travis WD, Brambilla E, Burke AP, Marx A, Nicolson AG (2015) WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed. Lyon, France: International Agency for Research on Cancer.
Gustafsson BI, Kidd M, Chan A (2008) Bronchopulmonary neuroendocrine tumors. Cancer 113: 5-21. Link: https://bit.ly/2Ipo1xO
Saqi A, Alexis D, Remotti F, Bhagat G (2005) Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids. Am J Clin Pathol 123: 394-404. Link: https://bit.ly/2ZwEjL3
Travis WD (2014) Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine. Thoracic Surg Clin 24: 257-266. Link: https://bit.ly/2ZuSJeP
Thomas C, Jett J, Strosberg J (2018) Lung neuroendocrine (carcinoid) tumors: Treatment and prognosis. UpToDate. Link: https://bit.ly/2IXJBZx